Electronic Symptom Monitoring Program for Triggered Palliative Referrals in Patients With
This clinical trial evaluates earlier symptom management through remote electronic symptom monitoring (such as through an app on patient's phone), and accessibility of palliative care self-referral by patients with thoracic cancer and caregivers by proxy (legal representative). Thoracic cancer occurs in the chest and o
| Condition(s) | Malignant Thoracic Neoplasm |
|---|---|
| Status | Recruiting |
| Phase | NA |
| Study type | Interventional |
| Summary | This clinical trial evaluates earlier symptom management through remote electronic symptom monitoring (such as through an app on patient's phone), and accessibility of palliative care self-referral by patients with thoracic cancer and caregivers by proxy (legal representative). Thoracic cancer occurs in the chest and often causes symptoms for patients. Patients and/or their caregivers are often unable to attend in-person clinic visits for various reasons. The most frequently reported symptom by patients at initial palliative care consultations is pain, and caregivers' most common concerns are pain management for the patient, stress reduction, and fears about patient decline. Earlier palliative care referral can help control these symptoms before they worsen, providing a better quality of l |
| Who can participate | Inclusion Criteria: * PATIENTS: Age ≥ 18 years * PATIENTS: Diagnosed with any stage (1-4) or type (non-small cell lung cancer, small cell lung cancer, mesothelioma, thymic carcinoma) of thoracic malignancy * PATIENTS: ≥ 2 visits at the Ohio State University Comprehensive Cancer Center (OSUCCC) Thoracic Oncology Clinic * PATIENTS: Study enrollment within 12 weeks of initial Thoracic Medical Oncology appointment * PATIENTS: Ability to understand and willingness to sign an informed consent document (or indicate approval or disapproval by another means) * PATIENTS: Ability to read and understand English * PATIENTS: Access to a device with email or text messaging capability * CAREGIVERS: Age ≥ 18 years * CAREGIVERS: Identified by patient participant as primary caregiver * CAREGIVERS: Correspond |
| Ages | 18 Years |
| Sex | All |
| Accepts healthy volunteers | Yes |
| Lead sponsor | Ohio State University Comprehensive Cancer Center |
| Locations | Columbus, Ohio, United States |
| Start date | 2024-02-09 |
| NCT ID | NCT06396598 |
| Official listing | https://clinicaltrials.gov/study/NCT06396598 |